More
    Guided Solutions - Connecting Talent With Innovation/div>

    Corvia Medical has positive data for atrial shunt

    Corvia Medical announced three-year positive results from its clinical trial of its Corvia Atrial Shunt. The REDUCE LAP-HF randomized trial evaluated the safety and efficacy...

    Shifamed’s Tioga Cardiovascular has first human cases with mitral valve replacement

    Tioga Cardiovascular, a Shifamed portfolio company, announced the first-in-human implants for its Luna TMVR system. Luna, a 28 Fr. transcatheter mitral valve replacement (TMVR) system,...

    Luna Diabetes launches trial for ‘world’s smallest insulin patch pump’

    Luna Diabetes launched a pivotal trial for Luna, its miniature automated insulin delivery system. The company describes the system — designed to transform nighttime...

    Nexalin trials Halo neurostimulation device in traumatic brain injury

    Nexalin Technology has partnered with the University of California, San Diego, to start a clinical trial evaluating the company’s neurostimulation device, Gen-3 Halo headset,...

    SeaStar hits halfway mark in AKI trial for selective cytopheretic device

    SeaStar Medical has announced a significant milestone in its pivotal NEUTRALIZE-AKI trial with 51 subjects enrolled, surpassing the halfway point toward its target of...

    Endospan completes enrolment in aortic arch stent graft study

    Endospan completed enrolment for the primary arm of its TRIOMPHE FDA investigational device exemption (IDE) trial. TRIOMPHE evaluates the safety and efficacy of the...

    Microbot Medical completes trial, set to submit surgical robot to FDA this year

    Microbot Medical successfully completed enrolment and follow-up in its surgical robot clinical trial. The Braintree, Massachusetts–based company completed enrolment and follow-up for all patients...

    Rivanna starts trial for AI-enabled Accuro XV imaging system

    Virginia-based Rivanna has initiated a feasibility study evaluating its artificial intelligence (AI) enabled Accuro XV musculoskeletal imaging system. The study will enrol 200 patients to...

    4C Medical commences enrolment in heart valve trial

    4C Medical Technologies commenced enrolment in its ATLAS pivotal trial evaluating its AltaValve system. ATLAS (a transseptal left atrial system for the treatment of...

    Latest articles